AstraZeneca CEO To Quit On June 1
AstraZeneca Chief Executive David Brennan is to step down on June 1 in an abrupt exit after six years in the top…
Browsing Tag
David Brennan
Europe Shares Inch Higher
European shares markets moved mostly higher on Thursday, as well-received results from heavyweight companies…
Ardea Agrees to AstraZeneca’s $32-Share Bid
AstraZeneca Plc (AZN) agreed to buy Ardea Biosciences Inc. (RDEA) for $1.26 billion to add experimental gout and…
